UK sugar and sweetener group Tate & Lyle has reported generally good trading at its two main starch and sweetener businesses, Staley in the US and Amylum in Europe.

Tate & Lyle said in a routine update that its trading had remained in line with its own expectations since the group’s last update at the end of January.

For the financial year through to 31 March 2003, Tate & Lyle said it expected Amylum to perform better than in the previous year and that benefits were flowing through earlier than expected from its full integration into the group.

In the US, Staley has increased profits from food ingredients this year, but its citric acid business has suffered due to strong competition, reported Reuters.